08/28/2012 | 30 | Minute Entry. Proceedings held before Chief Judge Margaret B Seymour: Motion Hearing held on 8/28/2012 re 6 MOTION for Preliminary Injunction filed by Ther-Rx Corporation, K-V Pharmaceutical Company. Court takes motion under advisement, written order forthcoming. Parties to notify court if they are able to work out prior to entry of order. Court Reporter Kathleen Richardson. (mdea ) (Entered: 08/28/2012) |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, August 29, 2012
K-V v. Keck: Court Takes Motion for Injunction Under Advisement
Complaint and Motion for Injunction in K-V v. Hamos et al (state of Illinois)
The case of K-V Pharmaceutical Company et al v. Hamos et al (which is the state of Illinois) has been assigned to the Honorable Joan H. Lefkow. To view the complaint click here. If anyone wants to see the exhibits to the complaint please let me know which exhibit number and I will download and post it.
To view the memorandum in support of K-V's request for injunctive relief against Illinois click here.
To view the memorandum in support of K-V's request for injunctive relief against Illinois click here.
Emerging Markets to Play a Key Role in the Pharmaceutical Industry's Growth
Full story: PR-inside.com
IMARC Group, one of the world's leading research and advisory firms, expects the emerging markets to play a key role in driving the growth of the pharmaceutical industry.
Unit Caraco Received US Ok to Resume Operations
Full story: Fox News
Indian generic drug maker Sun Pharmaceutical Industries Ltd. said Tuesday the U.S. drug regulator has allowed resumption of operations at unit Caraco Pharmaceutical Laboratories Ltd.'s manufacturing facility and packaging sites in Detriot and Wixom, Michigan.
Use of Compound Drugs in California's Workers' Compensation Program
The Working Papers, Use of Compound Drugs, Medical Foods, and Co-Packs in California’s
Workers’ Compensation Program, An Overview of the Issues, by BARBARA O. WYNN (January 2011) can be found here.
FDA Warning Letters in August
The following warning letters are found here:
August 16, 2012 | Farmers Coop Co33 | Kansas City District Office | CGMP/Medicated Feed/Adulterated | Not Issued * |
August 15, 2012 | Dragon Herbs34 | Los Angeles District Office | New Drug/Labeling/False & Misleading Claims | Not Issued * |
August 15, 2012 | Healing Ways35 | Los Angeles District Office | New Drug/Labeling/False & Misleading Claims | Not Issued * |
August 02, 2012 | HSAC Enterprises, Inc. dba Kare-N-Herbs36 | New England District Office | Drug/Labeling/False & Misleading Claims | Not Issued * |
Alarming Report About API from China
Melanie Lee and Ben Hirschler at Reuters have written a Special Report: China's "wild east" drug store dated August 28, 2012. This report contains alarming information about API from China. It should be read by everyone and serves as a reminder to ask questions about the source of API used by compounders. To read the report click here.
Tuesday, August 28, 2012
KV has Now Sued Illinois Over Payment for Makena
KV Pharmaceutical sues Illinois over payment for drug Makena
St. Louis Business Journal by Greta Weiderman, Web Editor
Date: Tuesday, August 28, 2012, 12:08pm CDT - Last Modified: Tuesday, August 28, 2012, 8:23pm CDTKV Pharmaceutical Co. sued the Illinois Department of Healthcare and Family Services to compel the state’s Medicaid program to pay the company more than $500 per injection of KV's Makena drug, instead of just $20 for non-branded versions.
To read the remainder of the article click here.
Collaborative Practice: Do We Need to Adopt Legislation?
Collaborative Practice: Do We Need to Adopt Legislation?
posted: 08/15/2012
posted: 08/15/2012
by Greg J. Baran, R.Ph., MPA director of governmental affairs, and Denise M. Pratt, Pharm.D., MSHP immediate past president
To read remainder of article click here.
There has been considerable discussion amongst the national pharmacy associations suggesting that states should enact collaborative practice legislation. At this time, 11 states are considering 27 bills related to collaborative practice. Several pharmacists have inquired as to whether MPA is pursuing legislation to allow pharmacists to participate in medication therapy management (MTM) programs by amending the Michigan Public Health Code to allow for collaborative practice agreements.
Subscribe to:
Posts (Atom)